Skip to Main Content
Home
Search
Study Topics
Glossary
Full Text View
Tabular View
No Study Results Posted
Related Studies
Do Xanthine Oxidase Inhibitors Reduce Both Left Ventricular Hypertrophy and Endothelial Dysfunction in Cardiovascular Patients With Renal Dysfunction?
This study is currently recruiting participants.
Study NCT00688480 Information provided by University of Dundee
First Received: May 29, 2008 Last Updated: July 10, 2008
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Kidney Disease
Left Ventricular Hypertrophy
Additional conditions recognized in this trial
Hypertrophy
Hypertrophy, Left Ventricular
Kidney Diseases
More general conditions related to this trial
Cardiomegaly
Cardiovascular Diseases
Heart Diseases
Pathological Conditions, Anatomical
Urologic Diseases
Interventions listed in this trial
Placebo
Allopurinol
More general drug interventions related to this trial
Antimetabolites
Antioxidants
Antirheumatic Agents
Enzyme Inhibitors
Free Radical Scavengers
Gout Suppressants
Molecular Mechanisms of Pharmacological Action
Pharmacologic Actions
Physiological Effects of Drugs
Protective Agents
Therapeutic Uses
Sponsors listed in this trial
University of Dundee
Back to top of Main Content